BioPartner Nordic ApS: Financial statements 2024
CVR: 38153188
Source: annual report 2024, Danish Business Authority
01/01/2024 – 31/12/2024
BioPartner Nordic ApS (CVR 38153188) has filed annual accounts for 2024. In 2024, the company reported revenue of DKK 4,200 and a net result of DKK -79,721 compared with DKK 94,330 the year before. That is a decrease of 98.3% compared with the year before. The profit margin was -1,898.1%. Equity in the 2024 report amounted to DKK -29,721.
- Revenue
- DKK 4,200
- Gross Profit
- DKK -47,187
- Profit/Loss
- DKK -79,721
- Equity
- DKK -29,721
- Total Assets
- DKK 886
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2024 | 4K | -47K | -80K | -30K | - |
| 2023 | 242K | 128K | 94K | -21K | - |
| 2022 | - | -13K | -43K | -115K | - |
| 2021 | 121K | 23K | -11K | 5K | - |
| 2020 | 240K | 78K | 56K | -62K | - |
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningEvents in 2024
BioPartner Nordic ApS has published its annual report for 2023. Revenue came to DKK 241,844, and the net result was DKK 94,330.
About BioPartner Nordic ApS
BioPartner Nordic ApS is a Danish company of the type Anpartsselskab based in Hedehusene, founded in 2016. The company is registered under the industry Anden teknisk rådgivning. The management consists of John Holger Schultz. The company is owned by John Holger Schultz. The company has 1 employee (2026). In 2025, the company reported a gross profit of DKK -7,778 and a net result of DKK -27,378 compared with DKK -79,721 the year before. Equity in the 2025 report amounted to DKK 22,622.
